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Summary
Chromosomal aberrations are a common cause of mul-
tiple anomaly syndromes that include developmental
and growth retardation. Current microscopic techniques
are useful for the detection of such aberrations but have
a limit of resolution that is above the threshold for phe-
notypic effect. We hypothesized that a genomewide mi-
crosatellite screen could detect chromosomal aberrations
that were not detected by standard cytogenetic tech-
niques in a portion of these individuals. To test this
hypothesis, we performed a genomewide microsatellite
screen of patients, by use of a currently available genetic-
marker panel that was originally designed for meiotic
mapping of Mendelian traits. We genotyped ∼400mark-
ers on 17 pairs of parents and their children who had
normal karyotypes. By using this approach, we detected
and confirmed two cases of segmental aneusomy among
11 children with multiple congenital anomalies. These
data demonstrate that a genomewide microsatellite scan
can be used to detect chromosomal aberrations that are
not detected by microscopic techniques.
Introduction
The development and refinement of cytogenetics have
led to the characterization of an array of malformation
syndromes caused by chromosomal aberrations ( Schin-
zel 1984; Borgaonkar 1994; Verma and Babu 1995).
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Progressive improvements in cytogenetic banding tech-
niques have allowed for determination of segmental
aneusomy, for chromosomal regions of as little as 2–5
Mb of duplication or deletion, under ideal conditions
(Ledbetter and Ballabio 1995). However, there exist no
data with which to assess the resolution of standard
banding techniques performed routinely in a clinical cy-
togenetics laboratory. The results of studies of contig-
uous-gene syndromes have demonstrated that duplica-
tions or deletions of chromosomal segments smaller than
2–5 Mb can cause multiple anomaly syndromes (Led-
better and Ballabio 1995; Mazzarella and Schlessinger
1998). Therefore, the lower limit of cytogenetic reso-
lution with the use of G-banding is above the threshold
for phenotypic effects.
Polymorphic markers can be used for the detection of
segmental aneusomy—specifically, for duplications and
deletions (Wilkie 1993). Such an approach contributed
to the isolation of the 1.5-Mb duplication in Charcot-
Marie-Tooth disease type 1A (Lupski et al. 1991). This
approach has also been used for the detection of terminal
chromosomal aberrations, by use of VNTR, RFLP (Flint
et al. 1995), and microsatellite (simple-tandem-repeat
polymorphism [STRP]) markers (Biesecker et al. 1995;
Slavotinek et al. 1999). This approach takes advantage
of the polymorphic alleles of meiotic mapping markers,
to search for non-Mendelian allele-inheritance patterns
that are compatible with aneuploidy or segmental aneu-
somy. These are most readily recognized when a marker
is fully informative and when an offspring has either
hemizygosity (e.g., shows only one of the four alleles)
or trisomy (e.g., shows three alleles). In this way, meiotic
markers can serve as probes for duplications and dele-
tions. Previous study groups have focused on terminal
chromosomal aberrations, since they are a common sub-
type of chromosomal rearrangement and since a panel
of informative subtelomeric markers can be combined
into a robust screen for such aberrations (Flint et al.
1995; Slavotinek et al. 1999). In contrast, the design of
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Figure 1 Distribution of markers used to screen subjects. The
two data sets represent the spacing of the Marshfield panel, version
7.0, in either genetic distance (diagonally hatched bars) or physical
distance (blackened bars). The genetic spacing of the panel is 10
cM, whereas the physical spacing is estimated to be Mb.3.5 8.4 7
a marker panel for interstitial aberrations is more chal-
lenging. Since each mating is fully informative for only
a fraction of markers and since the sensitivity of the
whole-genome screen is dependent on the density of in-
formative markers, the panel requires a large number of
informative and evenly spaced probes for a robust assay.
In this pilot study, we used an existing meiotic mapping
panel for the purpose of screening for duplications and
deletions, to assess both the practicality and the useful-
ness of such an approach.
Material and Methods
Patients
Seventeen families from two diagnostic categories
were analyzed in this study. Eleven of the children had
multiple congenital anomalies and were selected from a
pool of 120 such children from a larger study of a sub-
telomeric screening protocol. The 11 children were se-
lected because the available quantity of DNA was large
and because the results of a subtelomeric screen for de-
letions and duplications, done by use of microsatellite
markers, were normal (data not shown). The clinical
criteria for this group included: (1) at least three minor
anomalies or a major and a minor congenital anomaly,
(2) developmental or growth retardation, (3) no affected
first-degree relatives, (4) a normal GTG-banded karyo-
type, (5) no syndromic diagnosis, and (6) no known
consanguinity. Six children with VACTERL association
were selected, by similar means, from a pool of 80 chil-
dren. The diagnostic criteria for this group were (1) the
presence of three or more of the six anomalies that com-
prise this association, (2) a normal GTG-banded kary-
otype, (3) no affected first-degree relatives, and (4) no
known consanguinity. The study was reviewed and ap-
proved by the National Institutes of Health National
Cancer Institute institutional review board. G-banding
karyotype analysis was performed by use of standard
techniques.
Genotyping
Semiautomated genotyping was performed with the
use of a standard whole-genome marker panel (Center
for Medical Genetics, Marshfield Medical Research
Foundation). The markers in this panel are spaced for
optimal genetic distribution, not for physical distribu-
tion. To estimate the physical spacing of the marker set,
we searched the integrated mapping resource (The Ge-
netic Epidemiology Research Group, Department of Hu-
man Genetics, University of Southampton) for markers
that were present in the genetic mapping panel (Marsh-
field screening set, version 7.0). We then tallied all of
the intervals of adjacent markers and plotted those in-
tervals, whether physical (in Mb, ) or genetic (inn = 305
cM, ), to estimate the difference in genetic andn = 348
physical spacing of the panel (fig. 1). Manual genotyping
was done by incorporation of a[32P]-dCTP, as described
elsewhere (Biesecker et al. 1995).
For each marker, genotypes both of patients and of
their parents were compared to detect a missing allele
(deletion or uniparental isodisomy [UPID]), the presence
of a third allele or unequal intensity of two alleles (du-
plication), or the presence of two alleles from one parent
and no alleles from the other parent (uniparental het-
erodisomy [UPHD]). Deletions and UPID were distin-
guished by the presence or absence of signals from FISH
probes on homologous chromosomes, indicating UPID
or a deletion, respectively.
Screening of Libraries to Isolate Clones for FISH Probes
For the chromosome 9 experiments, filters from a
P1-derived-artificial-chromosome (PAC) library were
screened by hybridization. Seven filters containing hu-
man PAC clones (Genome Systems) were screened with
the use of multiple STRP probes. Each probe was syn-
thesized from a PCR fragment that had been amplified
by use of the appropriate STRP primers. Fifty nano-
grams of a PCR fragment and 5 ml of a 10-mM mixture
of forward and reverse primers were combined. The vol-
ume was increased to 33 ml with water and was then
incubated at 95C for 5 min. The solution was placed
on ice, and 5 ml 10# KGB buffer (1# 100 mM potas-
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sium glutamate, 25 mM Tris-acetate, pH 7.6, 10 mM
magnesium acetate, and 50 mg BSA/ml); 5 ml 2.5-mM
dATP, dGTP, and dTTP mix; 5 ml a[32P]-dCTP (3,000
Ci/mmol); and 2 ml Klenow polymerase were added. The
reaction was incubated at 37C for 30–60 min. Unin-
corporated nucleotides were removed by use of the Qia-
quick nucleotide removal kit (Qiagen). Filters were preh-
ybridized in roller bottles (no more than two per bottle),
with use of standard formamide hybridization solution
(Sambrook et al. 1989), at 42C for 2 h. Probes were
pooled and were mixed with 10 mg human Cot1 DNA
(Life Technologies), 10 mg poly dCA7dGT (Amersham
Pharmacia Biotech), and 100 ml 10-mg/ml sheared DNA
(Research Genetics). The mixture was denatured at 95C
for 5 min and then was incubated at 42C for 20 min.
The probe mixture was equally divided and was added
to the prehybridization mixture in each bottle. Filters
were incubated overnight and were washed the follow-
ing morning, in 0.1# SSC/0.1% SDS, at room temper-
ature for 15 min. The wash was repeated at 50C for
20 min. Filters were exposed to film for 2–3 d, were
rewashed in 0.1# SSC/0.1% SDS at 60C for 20 min,
and were exposed to film overnight. The autoradi-
ographs from the longer exposure were used to orient
the filters, and the autoradiographs from the shorter ex-
posure were used to select positive clones. Positive clones
were verified by means of PCR done with the use of
primers for the STRP probes. DNA was extracted by
means of standard alkaline lysis techniques. For the
chromosome 1 experiments, a P1 library was screened,
by means of PCR amplification of D1S1656 on a pooled
arrayed library (DuPont-Merck), by use of standard
techniques. Chromosome 19 cosmids were obtained
from Lawrence Livermore National Laboratory.
FISH
The cosmids, PACs, and P1s were directly labeledwith
Spectrum Orange (Vysis), by means of nick translation,
for use as probes in FISH studies. Probes were mixed
with Cot-1 DNA (Boehringer Mannheim) in a hybrid-
ization solution of 50% formamide in 2# SSC and were
denatured at 75C for 10 min. Metaphase preparations
from lymphoblastoid cells were dropped on glass slides
by means of standard techniques. The preparations were
treated with a graded ethanol series (70%, 80%, and
95%) for dehydration and were denatured in 70% for-
mamide in 2# SSC at 72C for 3 min. The cosmids and
PACs were hybridized to the preparations, and a ref-
erence probe for the chromosome of interest was in-
cluded in the hybridization. After hybridization, the
slides were washed in 1# SSC at 72C for 5 min, were
treated for detection of the digoxigenin with a fluores-
cently labeled antidigoxigenin antibody (Oncor), and
were counterstained with 4′, 6′-diamidine-2′-phenylin-
dole dihydrochloride (Boehringer Mannheim). The met-
aphases were analyzed with a Zeiss Axiophot micro-
scope equipped with an Applied Imaging Cytovision
system for FISH analysis. Metaphase preparations that
showed hybridization of the reference probe on both
homologues were scored for the presence or absence of
the signals. Ten metaphase preparations were scored for
each hybridization.
Results
Whole-Genome STRP Scanning
The study was performed on 17 children withmultiple
congenital anomalies and on their normal parents.
Eleven of these children had undiagnosed multiple con-
genital anomalies, and six had the VACTERL associa-
tion. Twelve of the families were genotyped by means
of the Marshfield marker screening set, version 6.0,
which consists of 393 di-, tri-, and tetranucleotide repeat
markers, and five families were typed by means of the
screening set, version 7.0, which consists of 396markers.
The genotypes of the children were compared with those
of their parents, to determine informativeness and to
search for families that had evidence of non-Mendelian
inheritance suggestive of segmental aneusomy or uni-
parental disomy (UPD) (Wilkie 1993). This approach
generated 20,088 potential genotypes, of which 346
were uninterpretable, for a failure rate of 1.7%. Because
the failure of one, two, or three genotypes for a single
marker within a nuclear family commonly results in the
inability to determine inheritance patterns, failures were
counted by family and not by individual. The total num-
ber of markers genotyped for all 17 families was 6,696.
Of these, 328 had amplification failure of at least one
family member’s DNA, for a failure rate of 4.9%. All
genotypes that failed to generate an interpretable result
were repeated manually by use of a[32P]-dCTP labeling,
gel electrophoresis, and autoradiography. Fifty-three of
the manually repeated genotypes failed to give a usable
result, yielding a final failure rate of 0.8%. The inter-
pretable genotypes were reviewed manually for evidence
of non-Mendelian inheritance.
In the initial scan, there were 42 markers for which
allele inheritance patterns were incompatible with Men-
delian inheritance patterns. In 27 of these non-Mende-
lian results, the child had an allele that was not present
in either parent, and these genotypes were repeatedman-
ually. Twenty of them were reproducible, and these al-
terations were judged to be STRP mutations. The fre-
quency of mutations in this sample set (∼.3%) is
comparable to results described elsewhere (Weber and
Wong 1993; Brinkmann et al. 1998). Nonpaternity was
excluded in all cases, because of the large number of
other markers that were compatible with paternity.
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There were 12 markers from the initial scan for which
the child was missing an allele. After reamplification
with either the same or a different set of primers for each
marker, only four remained abnormal. Finally, there was
one marker with a genotype that was compatible with
trisomy, since the child’s sample had three alleles, and
there were two markers with genotypes that were com-
patible with UPHD. In both cases of apparent UPHD
(in family 57 with D19S714 and in family 161 with
D2S2944, located on chromosome 2), the child was
missing a paternal allele. Flanking markers showed the
presence of a paternal allele in both cases. Although the
possibility of a small region of segmental UPHD cannot
be excluded, it is more likely that the non-Mendelian
pattern is the result of a mutation in a paternal allele,
so that the final repeat length is, coincidentally, the same
as that of the mother’s other allele.
For all interpretable markers, we calculated the per-
centage that excluded the presence of a duplication or
a deletion. The sensitivity of the markers used in this
study was 77% for monosomy (deletion) and 60% for
trisomy (duplication.) Among the genotypes ascertained
in this study, there were four loci among three families
where an abnormal STRP result suggesting a duplication
or deletion was detected and confirmed. These results
are described in the following sections.
Family 14
Family 14 had three anomalous genotypes, two of
which (D4S1644 and D4S1625) suggested a deletion
of maternal alleles for adjacent markers on chromo-
some 4q (fig. 2A). Because null alleles can cause false-
positive results for a deletion, the genotypes were con-
firmed by manual genotyping performed with either
the published primers or with multiple custom primer
pairs. An additional 41 markers on chromosome 4q
were genotyped to confirm the finding and to define
the size of the 4q deletion (data not shown). These
markers were selected from the Southampton inte-
grated map database (Collins et al. 1996). Ten of these
41 markers also showed missing maternal alleles.
These data suggested that the child had a deletion of
11–15 Mb of chromosome 4q. On the basis of these
results, a repeat karyotype at 500–550-band resolu-
tion was performed; it showed 46,XY,del(4)
(q28q31.3) (fig. 2B). When the original karyotype
(which was reported as normal) was reviewed, it was
apparent that the quality of the study was suboptimal
and that the deletion was not detected because of the
poor resolution of that study. In addition to the results
for chromosome 4, a marker on chromosome 1q
(D1S1656) was found to be compatible with a pater-
nal deletion (data not shown). The results of analyses
of 16 flanking markers on chromosome 1q demon-
strated no other genotypes that were suggestive of a
deletion (data not shown). Marker D1S1656 was used
to isolate a P1 clone, which was then used for FISH
analysis. This probe showed a signal on both copies
of chromosome 1 in all metaphase spreads, suggesting
that the child and father carry a null allele for this
marker or that an allele mutation has occurred in the
child (data not shown). However, the presence of a
deletion that is too small to be detected by FISH can-
not be excluded.
The affected child in family 14 is 9 years old and has
multiple minor anomalies with developmental and
growth retardation and microcephaly. On physical ex-
amination, he had a flat mid-face, retrognathia, simple
and asymmetrically placed ears, down-slanting palpe-
bral fissures with epicanthal folds, intermittent nystag-
mus, and 5th-finger clinodactyly. These features are non-
specific but have previously been described in interstitial
deletions of chromosome 4q (Lin et al. 1988).
Family 143
Semiautomated genotyping results for marker
D19S245 did not detect a paternal allele in this child
(fig. 3A). Ten additional markers were tested, with
three of them confirming the absence of a paternal
allele. The size of the monosomic segment was esti-
mated to be 9–11 Mb from the Southampton inte-
grated map in band 19q12 or 19q13.1. Repeat kar-
yotyping with resolution of up to 600 bands showed
no clear deletion of material in this region of chro-
mosome 19 (fig 3B, inset). FISH analyses done with
the use of four probes (23036, 17755, 30016, and
20809), each of which contained one of the four hem-
izygous STRP markers, showed an absent signal on
one chromosome 19 homologue, in metaphase
spreads of lymphoblasts from the proband (fig 3B).
No deletions were detected in the parental meta-
phases, by use of these four probes (data not shown).
The clinical features of this child included hypotonia,
developmental delay, and visual problems, including
astigmatism, hyperopia, and esotropia. He had minor
dysmorphic features, including dolichocephaly, a high
frontal hairline, prominent and low-set ears, a low der-
mal ridge count, and hypoplastic toenails. He has un-
dergone tracheal reconstruction for subglottic stenosis
and strabismus repair.
Family 24
In family 24, marker GATA62F03 (listed as both
D9S2169 and D9S935) was reported, from the sem-
iautomated genotyping screen, as a nonamplification
in the child and as having bands of unequal intensity
in both the child and the father. Reamplification of
this marker revealed that the child had three alleles
Figure 2 Genotypic and cytogenetic analyses of family 14. A, Genotyping results of representative markers from the deleted region on chromosome 4q. D4S1644 and D4S1625 were part of
the whole-genome-scan marker set and were repeated by use of radioactive genotyping. Both markers indicate that the child is missing a maternal allele. D4S2395 and D4S2908 are the closest flanking
markers that exclude a deletion. M denotes mother; C, child; and F, father. B, Partial karyotype of the affected child shows a deletion of 4q28q31.3.
Figure 3 Genotypic and cytogenetic analyses of family 143. A, Genotyping results of representative markers from the deleted region on
chromosome 19q. D19S245 was part of the whole-genome-scan marker set and was repeated manually. The results show that the child is
missing a paternal allele. D19S255 and D19S200 are flanking markers that demonstrate biparental inheritance of alleles. M denotes mother;
C, child; and F, father. B, FISH analysis performed with the use of PAC probe 23036 that contained D19S414, which was hemizygous by STRP
analysis. This probe shows a signal from only one chromosome 19 homologue in the affected child. The inset of a partial-karyotype G-band
analysis of lymphocytes from the child shows no visible deletion of chromosome 19q at the 600-band stage. The normal G-band pattern and
p:q arm ratio are preserved. The p arm on lower-right chromosome 19 appears to be dark because it was overlapped in the metaphase.
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Figure 4 Genotypic analyses of family 24. GATA62F03
(D9S2169 or D9S935) was part of the whole-genome-scan marker set
and was repeated radioactively. D9S935 uses a different primer pair
to amplify the same repeat as GATA62F03 (D9S2169). Both clearly
show both the presence of three alleles in the child’s sample and a
consistent intensity difference of the father’s upper and lower alleles.
D9S286 and D9S1676 are nearby flanking markers that exclude tri-
somy and that do not show an intensity difference between the father’s
alleles. M denotes mother; C, child; and F, father.
of equal intensity and that the father’s 291-bp allele
was darker than the 283-bp allele, suggesting that he
may be trisomic as well (fig. 4). Detection of trisomy
by the observation of unequal intensity of STRP alleles
has been described elsewhere (Stone et al. 1996).
Twenty-three additional markers from this region
were amplified. None had genotypes that confirmed
the duplication in the child or that had evidence of
unequal band intensity. The most likely explanation
for these results is that one of the father’s chromosome
9 homologues has both a 291- and a 283-bp allele for
GATA62F03 and that his other homologue contains
one 291-bp allele. The child then inherited, from his
father, a chromosome containing the duplicated
marker and, from his mother, a normal chromosome
containing a 287-bp allele.
A PAC clone that was isolated (using GATA62F03 as
a probe) and then used for FISH analysis of the child
showed two signals on 9pter in all metaphases examined,
indicating that the duplication must be small. Fiber FISH
was performed and did not show evidence of a dupli-
cation. Because the duplication is likely to be present in
both the father and the child, it is unlikely that this
finding is a cause of the anomalies in the child. However,
we cannot exclude the possibility of an imprinting effect,
although current data show no evidence of imprinting
on chromosome 9 (Ledbetter and Engel 1995).
Discussion
This study was designed to test the feasibility of
using a whole-genome STRP-scanning approach for
the detection of segmental aneusomy. It was not de-
signed to compare the positive or negative predictive
power of this approach compared with that of current
technology, primarily GTG-banded karyotyping. In-
stead, we sought to learn how the STRP approach
might be implemented, what technical problems might
be encountered, and how positive screening results
could be evaluated. This study did not include a re-
view of either the previous karyotypes of the patients
or the repeat standard GTG-banded karyotypes. This
was a deliberate strategy, used to allow inclusion of
patients who have chromosomal aberrations that were
unknown to us but that may be detectable by a STRP
whole-genome screening technique. Other studies
have used genetic markers to search for terminal re-
arrangements, with yields of 6%–18% when adjusted
for the informativeness of the markers (Flint et al.
1995; Slavotinek et al. 1999). This pilot study ex-
plored the feasibility of generalization of the STRP
approach from a terminal-rearrangement screen to a
whole-genome screen.
The results of this study demonstrate three impor-
tant considerations that can be applied to any whole-
genome segmental aneusomy molecular-screening
technique. First, the technique can detect chromoso-
mal aberrations that are not detected by GTG band-
ing, since they are of inadequate band resolution. One
of the subjects (from family 14) in this study had re-
sults of a chromosomal analysis that, on retrospective
review, were found to be significantly substandard.
This chromosome analysis, although adequate to ex-
clude aneuploidy, was inadequate for the detection of
segmental aneusomy. However, that such an individ-
ual was found allows for a proof of principle that
microsatellite screening can detect such aberrations.
This result is not surprising, but it afforded an op-
portunity to evaluate the approach and to demon-
strate how STRP screening can detect such abnor-
malities and how they would subsequently be
confirmed by means of high-quality GTG-banded cy-
togenetics directed at the region determined by ab-
normal STRP results.
Second, the microsatellite-screening technique will
generate false-positive results because of genomic poly-
morphisms that are not related to the abnormality in
the patient (e.g., as in family 24 and family 14, for the
chromosome 1q marker). This is an important consid-
eration, since the generation of such results necessitates
follow-up studies to either confirm or refute the findings.
Such follow-up studies would need to be individualized
for each patient and would be challenging and expensive
to implement clinically with current technology.
Third, the technique has the potential to diagnose ab-
errations that are difficult or impossible to detect with
high-quality GTG-banded cytogenetic analysis (e.g., as
in family 143). In contrast to the findings for family 14,
the original karyotype of the child in family 143 was of
good quality, and a repeat karyotype, at 400- and 600-
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band resolution, was normal—even with the knowledge
of the chromosome 19q molecular data. The aberration
was confirmed only by FISH studies, by use of cosmid
probes that included the aberrant STRP markers. The
ability to detect such alterations would be very useful
both for clinical care and for the isolation of genes that
are important for normal development. All three of these
results were obtained in patients who had undiagnosed
multiple congenital anomalies; none were found among
the six patients with VACTERL association. In addition,
both of the aberrations that were confirmed were de-
letions, and no duplications or disorders of parental or-
igin (UPD) were detected. This may be attributable to
the fact that genetic-marker analysis for segmental aneu-
somy has a higher power to detect deletions than du-
plications (Wilkie 1993), although the sample size of this
study was too small to make conclusions about the rel-
ative numbers of duplications, deletions, or UPD.
The alternatives to genotyping, for whole-genome
screening for chromosomal aberrations, include com-
parative genomic hybridization (CGH) and multicolor
FISH. CGH has been attempted, with some success, for
the detection of terminal rearrangements, although the
sensitivity and applicability of this technique are not
known (Ghaffari et al. 1998). The usefulness of CGH
for the detection of unbalanced interstitial structural ab-
normalities is unknown. The recent development of mul-
ticolor FISH techniques shows excellent promise for clin-
ical cytogenetics (Schro¨ck et al. 1996; Speicher et al.
1996; Uhrig et al. 1999). However, the sensitivity of 24-
color FISH done, by use of whole-chromosome paints,
for the detection of intrachromosomal rearrangements
is inadequate. These considerations suggest that geno-
typing may be more sensitive for the detection of inter-
stitial aberrations, compared with either CGH or 24-
color FISH. Currently, the cost of a whole-genome scan
is substantial, but it is likely that progress in automation
(Wang et al. 1998) will make this technique more af-
fordable. In any case, it is difficult to imagine that any
single technique will offer a high degree of sensitivity
for all types of structural or numerical chromosome ab-
normalities. The ongoing development of a variety of
techniques for the detection of chromosomal aberrations
has created a need for prospective studies to determine
which types of tests are most informative and efficient
in clinical applications.
In addition to its potential clinical usefulness, the
whole-genome microsatellite technique would allow for
the determination of the true rate of small cytogenetic
aberrations and for the delineation of additional con-
tiguous gene syndromes. The sensitivity of GTG-banded
cytogenetics is dependent on the generation of an altered
banding pattern by the aberration. Because the density
of GTG bands is not uniform throughout the genome,
areas with less-distinct banding patterns are more dif-
ficult to analyze (e.g., distal chromosome 1p and chro-
mosomes 19 and 22 [Schinzel 1981]). This suggests that
current knowledge of the size range and location of clin-
ically significant cytogenetic aberrations is biased by use
of the GTG-banding detection technique. High-density
microsatellite analyses would allow for ascertainment of
such aberrations, independent of the cytogenetic band-
ing pattern. A future challenge will be to develop panels
of markers that are spaced at physical intervals, instead
of using the genetically spaced marker panels used in
this study. In addition, a fruitful approach may include
the application of panels with higher marker density in
areas of the genome known to have less-distinct banding
patterns. Such studies could be used as a research tool
to determine the true frequency and distribution of seg-
mental aneusomy and to search for submicroscopic al-
terations in syndromes that are hypothesized to be the
result of these chromosomal aberrations. The use of
thousands of markers in carefully selected patients could
be a powerful tool for the molecular characterization of
these syndromes.
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